Ziprasidone Hydrochloride Patent Expiration
Ziprasidone Hydrochloride is Used for managing symptoms of bipolar disorder, neuroleptic diseases, and psychosis. It was first introduced by Viatris Specialty Llc
Ziprasidone Hydrochloride Patents
Given below is the list of patents protecting Ziprasidone Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Geodon | US7175855 | Ziprasidone suspension |
May 18, 2020
(Expired) | Pfizer Inc |
| Geodon | US6150366 | Ziprasidone formulations |
May 27, 2019
(Expired) | Pfizer Inc |
| Geodon | US6150366 | Ziprasidone formulations |
May 27, 2019
(Expired) | Viatris |
| Geodon | US6245766 | Method of treating psychiatric conditions |
Dec 18, 2018
(Expired) | Pfizer Inc |
| Geodon | US6245766 | Method of treating psychiatric conditions |
Dec 18, 2018
(Expired) | Viatris |
| Geodon | US5312925 | Monohydrate of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2H-indol-2-one-hydrochloride |
Sep 01, 2012
(Expired) | Pfizer Inc |
| Geodon | US5312925 | Monohydrate of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2H-indol-2-one-hydrochloride |
Sep 01, 2012
(Expired) | Viatris |
Ziprasidone Hydrochloride's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List